MediAim – new therapeutic and drug development strategies

June 25, 2020

All team of IOCB Tech is proud that IOCB Prague has become one of the strategic institutes in the MediAim consortium, which brings together three centers of excellence in science, research, and clinical practice.

The Institute for Clinical and Experimental Medicine (IKEM) and two institutes of the Czech Academy of Sciences – the Institute of the Organic Chemistry and Biochemistry (IOCB) and the Institute of Physiology (IPHYS) – have joined forces to seek out new strategies for treating cardiovascular, viral, neurodegenerative, and oncologic diseases as well as diabetes and obesity.

More here